An alternative strategy targeting furin disrupts SARS-CoV-2 infection cycle
A new study was based on the hypothesis that competitively inhibiting cellular furin and selectively targeting SARS-CoV-2 in the infected viral-producing cells is critical for therapeutic specificity.